Table 1.
Patient characteristics (N = 98) | Percentage of total (n) | |
---|---|---|
Gender | Female | 64 % (63) |
Age | >64 years | 62 % (61) |
Mean age | 67 years | |
Co-morbidity | Pulmonary disease | 42 % (41) |
Diabetes | 33 % (32) | |
Coronary disease | 31 % (30) | |
Kidney disease | 25 % (24) | |
Cancer | 24 % (23) | |
Symptoms | Abdominal pain | 60 % (59) |
Fever | 32 % (31) | |
Stool mucus | 23 % (22) | |
Stool blood | 12 % (12) | |
Stool consistency at assessment | Bristol 6–7 (unformed) | 62 % (61) |
Bristol 4–5 (soft formed) | 36 % (35) | |
Bristol 1–3 (hard formed) | 2 % (2) | |
Overall clinical condition | Severe | 25 % (24) |
Moderate | 67 % (66) | |
Mild | 8 % (8) | |
Patient history | Antibiotics | 75 % (73) |
Antibiotics and CDI | 14 % (14) | |
No prior antibiotics | 10 % (10) | |
CDI with no antibiotics | 1 % (1) | |
Culture | Toxigenic CDI | 87 % (85) |
Nontoxigenic CDI | 6 % (6) | |
Mixed | 1 % (1) | |
No growth | 6 % (6) | |
Ribotype | 027 | 45 % (38) |
Non-027 | 55 % (47) |